1. Division of Hematology, Department of Medicine, University Hospital Ospedale di Circolo e Fondazione Macchi, Varese, Italy;
2. Hematology Department, Hospital Clínic, Institut d'investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;
3. Section of Hematology, Department of Critical Care, University of Florence, Florence, Italy;
4. Division of Hematology, Ospedale Niguarda Cà Granda, Milano, Italy;
5. Hematology Department and Research Foundation, Ospedali Riuniti, Bergamo, Italy;
6. Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
7. Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;
8. Service d’Hematologie Cliniques universitaires Saint-Luc and Institut de Duve, Universite Catholique de Louvain, Brussels, Belgium;
9. Hôpital Saint-Louis and Université Paris Diderot, Paris, France;
10. Novartis Pharma AG, Basel, Switzerland; and
11. Guy’s and St. Thomas’ National Health Service Foundation Trust, Guy’s Hospital, London, United Kingdom